These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 39370170)

  • 1. Recent Advances in Medicinal Chemistry of Memantine Against Alzheimer's Disease.
    Singh YP; Kumar H
    Chem Biol Drug Des; 2024 Oct; 104(4):e14638. PubMed ID: 39370170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on drug treatment options of Alzheimer's disease.
    Allgaier M; Allgaier C
    Front Biosci (Landmark Ed); 2014 Jun; 19(8):1345-54. PubMed ID: 24896354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-modifying drugs in Alzheimer's disease.
    Ghezzi L; Scarpini E; Galimberti D
    Drug Des Devel Ther; 2013 Dec; 7():1471-8. PubMed ID: 24353405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease: emerging trends in small molecule therapies.
    Mohamed T; Rao PP
    Curr Med Chem; 2011; 18(28):4299-320. PubMed ID: 21861820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.
    Standridge JB
    Clin Ther; 2004 May; 26(5):615-30. PubMed ID: 15220008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Progress in the Pharmacotherapy of Alzheimer's Disease.
    Khoury R; Patel K; Gold J; Hinds S; Grossberg GT
    Drugs Aging; 2017 Nov; 34(11):811-820. PubMed ID: 29116600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the rationale for new treatment strategies in Alzheimer's disease?
    Rogawski MA
    CNS Spectr; 2004 Jul; 9(7 Suppl 5):6-12. PubMed ID: 15241294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New treatment strategies for Alzheimer's disease: is there a hope?
    Aprahamian I; Stella F; Forlenza OV
    Indian J Med Res; 2013 Oct; 138(4):449-60. PubMed ID: 24434253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.
    Ruthirakuhan M; Herrmann N; Suridjan I; Abraham EH; Farber I; Lanctôt KL
    Expert Opin Pharmacother; 2016 Dec; 17(18):2417-2429. PubMed ID: 27825018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memantine Derivatives as Multitarget Agents in Alzheimer's Disease.
    Marotta G; Basagni F; Rosini M; Minarini A
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32887400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on Alzheimer's disease pathophysiology and its management: an update.
    Kumar A; Singh A; Ekavali
    Pharmacol Rep; 2015 Apr; 67(2):195-203. PubMed ID: 25712639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease.
    Rosini M; Simoni E; Caporaso R; Basagni F; Catanzaro M; Abu IF; Fagiani F; Fusco F; Masuzzo S; Albani D; Lanni C; Mellor IR; Minarini A
    Eur J Med Chem; 2019 Oct; 180():111-120. PubMed ID: 31301562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
    Song MS; Rauw G; Baker GB; Kar S
    Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease.
    Kaniakova M; Nepovimova E; Kleteckova L; Skrenkova K; Holubova K; Chrienova Z; Hepnarova V; Kucera T; Kobrlova T; Vales K; Korabecny J; Soukup O; Horak M
    Curr Alzheimer Res; 2019; 16(9):821-833. PubMed ID: 30819076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease.
    Rogawski MA; Wenk GL
    CNS Drug Rev; 2003; 9(3):275-308. PubMed ID: 14530799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
    Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
    Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in the Treatment and Management of Alzheimer's Disease: A Precision Medicine Perspective.
    Shukla D; Suryavanshi A; Bharti SK; Asati V; Mahapatra DK
    Curr Top Med Chem; 2024; 24(19):1699-1737. PubMed ID: 38566385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
    Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
    Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.